Eledon Pharmaceuticals (ELDN) Change in Acquisitions & Divestments (2016 - 2026)

Eledon Pharmaceuticals' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $49.1 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 37.31% year-over-year to $49.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185.3 million (up 87.4% YoY) and the FY2025 annual result came in at $171.9 million, up 100.34% from the prior year.
• Change in Acquisitions & Divestments was $49.1 million for Q1 2026 at Eledon Pharmaceuticals, up from $48.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $49.1 million in Q1 2026 and bottomed at $16.4 million in Q2 2024.
• A 4-year average of $33.5 million and a median of $31.9 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments decreased 9.29% — and 2025, when it surged 158.3%.
• Eledon Pharmaceuticals' Change in Acquisitions & Divestments stood at $28.0 million in 2023, then dropped by 9.29% to $25.4 million in 2024, then soared by 91.98% to $48.8 million in 2025, then gained by 0.65% to $49.1 million in 2026.
• Business Quant data shows ELDN's Change in Acquisitions & Divestments at $49.1 million in Q1 2026, $48.8 million in Q4 2025, and $45.1 million in Q3 2025.